focus -WSS

focus

author：knowledge 2025-09-27 10:58:35 Page View：28154

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： EF3 tornado rips through North Carolina amid extreme weather nationwide
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

explore

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Mass General totes up its waste in a move to tackle climate change

OnanAugustThursdayin2021,deepintothepandemic,twoMassachusettsGeneralHospitaldoctorsstoodgowned,glove

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Senate panel passes drug pricing bills, but drops one PBM reform

CommitteeRankingRepublicanBillCassidy(La.)andChairmanBernieSanders(I-Vt.)ChipSomodevilla/GettyImages